Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
07/2012
07/04/2012EP2471786A1 Aminopyrazole derivative
07/04/2012EP2471774A1 Piperidinyl derivatives as modulators of chemokine receptor activity
07/04/2012EP2471773A1 Piperidinyl derivatives as modulators of chemokine receptor activity
07/04/2012EP2470541A1 Raf inhibitor compounds and methods of use thereof
07/04/2012EP2470014A1 Hiv integrase inhibitors
07/04/2012EP1817036B1 Modulators of muscarinic receptors
07/04/2012EP1689233B1 Bicyclic inhibitors of mek
07/04/2012CN1631878B C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides
07/04/2012CN102548557A Compounds for the reduction of beta-amyloid production
07/04/2012CN102532151A 7-ethyl-20(S)-O-substituted benzoyl camptothecin compounds with anticancer activity
07/04/2012CN102532150A Alkoxyl dibenzoazepine compound, and preparation method and medical application thereof
07/04/2012CN102532149A Asymmetric synthesis method for galanthamine and lycoramine
07/04/2012CN102532148A Compound with anti-tumor effect in zephyranthes candida and separation preparation method and application thereof
07/04/2012CN102532147A Preparation method of high purity dictamnine monomer
07/04/2012CN102532088A Indeno-fused photochromic naphthopyrans, naphthols and photochromic articles
07/04/2012CN102532021A Preparation method of 2-alkoxy-3,4-disubstituted isoquinoline-1(2H)-one derivatives
07/04/2012CN102532019A Method for preparing multi-substituted isoquinoline and analogues thereof
07/04/2012CN102531815A Method for asymmetric catalyzing epoxidation reaction of alpha, beta-unsaturated carbonyl compounds
07/04/2012CN102127087B Quinazoline derivatives
07/04/2012CN101973996B Imide biotin intermediate monoester and preparation method and use thereof
07/04/2012CN101948472B Novel staurosporine analogue and preparation method and applications thereof
07/04/2012CN101880285B Method for synthetizing allyl-substituted camptothecin compound
07/04/2012CN101845018B Non-catechol aporphine compound as well as pharmaceutic composition and application thereof
07/04/2012CN101824060B Ion pair medicine from traditional Chinese medicine extracts as well as preparation method and application thereof
07/04/2012CN101583615B Spiropiperidine glycinamide derivatives
07/04/2012CN101563323B Spiro-piperidine derivatives
07/04/2012CN101553493B Novel tricyclic spiropiperidine compounds, their synthesis and their uses as modulators of chemokine receptor activity
07/04/2012CN101475574B Camptothecin derivative, and preparation and use thereof
07/04/2012CN101391998B High efficiency separation and purification method of camptothecine
07/04/2012CN101362767B Method for preparing pyrrolidine dispiros compound intermediate
07/04/2012CN101128197B Preventive or therapeutic agent for cardiac dysfunction or myocardial damage caused by ischemia or ischemia-reperfusion
07/03/2012US8212029 Method for the production of high-purity 4a, 5, 9, 10, 11, 12,-hexahydro-6H-benzofuro [3a, 3, 2-ef] [2] benzazepine, and the derivatives thereof
07/03/2012US8211921 Heterocyclic inhibitors of MEK and methods of use
07/03/2012CA2568356C Bicyclic heterocycles as hiv integrase inhibitors
06/2012
06/28/2012WO2012087237A1 Compounds and their use as bace inhibitors
06/28/2012WO2012085662A1 2-amino-4-arylthiazole compounds as trpa1 antagonists
06/28/2012WO2012085222A1 Novel phenazine derivatives and their use
06/28/2012WO2012085126A1 Oxindolopyrimidine as igf1r receptor inhibitors
06/28/2012US20120165547 Supports for oligomer synthesis
06/28/2012US20120165546 Process for the asymmetric hydrogenation of imides
06/28/2012US20120165545 PROCESSES FOR THE PREPARATION OF 5-CHLORO-2-METHYL-2,3,3A,12b-TETRAHYDRO-1H-DIBENZO[2,3:6,7]OXEPINO[4,5-c]PYRROLE
06/28/2012US20120165522 Camptothecin derivatives
06/28/2012US20120165364 Novel forms of tiotropium bromide and processes for preparation thereof
06/28/2012US20120165356 Spirocyclic heterocyclic derivatives and methods of their use
06/28/2012US20120165347 Compounds and their use as BACE Inhibitors
06/28/2012US20120165327 Spiropiperidines for use as tryptase inhibitors
06/28/2012US20120165313 Pyrimidine compounds, compositions and methods of use
06/28/2012US20120165308 Use of parthenolide derivatives as antileukemic and cytotoxic agents
06/28/2012US20120165304 6,7,8,9-Tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
06/28/2012US20120164458 Curable Coating Composition Modified with a Cleavable Surfactant for Improving Adhesion in Multilayered Coating Stacks
06/28/2012CA2822378A1 Compounds and their use as bace inhibitors
06/28/2012CA2820448A1 2-amino-4-arylthiazole compounds as trpa1 antagonists
06/27/2012EP2468751A2 Processes for the preparation of 5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole
06/27/2012EP2468750A1 Polymorphic forms of asenapine maleate and processes for their preparation
06/27/2012EP2468748A1 Pyrazoloquinolones are potent parp inhibitors
06/27/2012EP2468744A2 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
06/27/2012EP2468743A1 Nitrogen-containing bicyclic compounds useful as antibacterial agents
06/27/2012EP2467387A1 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
06/27/2012EP2467385A1 Renin inhibitors
06/27/2012EP2467364A2 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
06/27/2012EP1389611B1 20-hydroxyeicosatetraenoic acid production inhibitors
06/27/2012CN102516992A Fluorescent probe for detection Hg<2+> ion, and synthetic method and purpose thereof
06/27/2012CN102516258A Water-soluble vitamin E derivative modified fat-soluble anti-cancer drug compound and preparation, preparation method and application of compound
06/27/2012CN102516257A Method for extracting thalicimine from shortstalk slimtop meadowrue root
06/27/2012CN102516256A Preparation method of epoxy isoindole derivative
06/27/2012CN102516255A Method for extracting cassyfiline from cassytha
06/27/2012CN102516254A Rhodamine derivatives and their preparation method and use
06/27/2012CN102516253A Method for synthesizing 3,4-dihydro-2H-pyrano[3,2-b]pyridine
06/27/2012CN102516252A Preparation method of Nedocromil sodium
06/27/2012CN102516221A Dibenzyl-macrolide compound based on photoreaction and synthesis method thereof
06/27/2012CN102516155A 2-alkoxy-4-halo-6-alkylphenyl-substituted (hetero)cyclic ketoenols
06/27/2012CN102516152A Alpha-difluoro carbonyl substituted chiral tert-alcohol compound, its synthetic method and application thereof
06/27/2012CN101892181B Streptoseomycin and preparation method and application thereof
06/27/2012CN101775020B Poly-substituted chromone pyrrole compound and synthetic method and application thereof
06/26/2012US8207340 Imidazopyridinyl benzamide mitotic kinesin inhibitors
06/26/2012US8207331 Benzazepine derivatives for the treatment of neurological disorders
06/26/2012US8207188 Treatment of diseases modulated by a H4 receptor agonist
06/26/2012US8207173 Benzimidazoles and analogs thereof as antivirals
06/26/2012US8207159 for the treatment of disorders of the central nervous system such as cerebral, central nervous or psychiatric symptoms, defunctionalization manifestations or disorders which occur as a result of unintentional or intentional intake of psychotropic
06/26/2012US8207158 5HT2c receptor modulators
06/21/2012WO2012082997A1 Tricyclic pi3k inhibitor compounds and methods of use
06/21/2012WO2012080476A1 Fused dihydropyrans as gpr119 modulators for the treatment of diabetes, obesity and related diseases
06/21/2012WO2012080456A1 Bicyclic ring system substituted amide functionalised phenols as medicaments
06/21/2012WO2012080195A2 Polymorphic forms of asenapine maleate and processes for their preparation
06/21/2012WO2012025187A3 Furopyridine derivatives
06/21/2012US20120157461 Indolyl-Substituted Pyrazino-Quinolines and Their Use for the Treatment of Cancer
06/21/2012US20120157453 Raf inhibitor compounds and methods of use thereof
06/21/2012US20120157448 Compounds for treating neurodegenerative diseases
06/21/2012US20120157440 Novel fused pyridine compounds as casein kinase inhibitors
06/21/2012US20120157411 2-amino-4-arylthiazole compounds as trpai antagonists
06/21/2012US20120156212 Methods and compositions for treating neoplasia
06/21/2012CA2821211A1 Polymorphic forms of asenapine maleate and processes for their preparation
06/21/2012CA2820078A1 Tricyclic pi3k inhibitor compounds and methods of use
06/20/2012EP2464628A1 Bi - or tricyclic sterically hindered alkoxyamines and process for their preparation
06/20/2012EP2464227A1 Compounds and methods of use thereof
06/20/2012EP2148882B1 Process for making topotecan
06/20/2012CN102510867A Glycoside derivative and uses thereof
06/20/2012CN102503948A Method for separating and purifying fumarilline
06/20/2012CN101528750B Benzimidazole derivatives as selective acid pump inhibitors
06/19/2012CA2504448C Transcription factor modulating compounds and methods of use thereof
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 298